Gilder Gagnon Howe & Co. LLC purchased a new stake in shares of Confluent, Inc. (NASDAQ:CFLT - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The fund purchased 135,467 shares of the company's stock, valued at approximately $3,788,000.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Credit Industriel ET Commercial purchased a new stake in Confluent in the fourth quarter worth $28,000. Fuller & Thaler Asset Management Inc. purchased a new position in shares of Confluent in the fourth quarter worth $64,658,000. Quantessence Capital LLC purchased a new stake in shares of Confluent during the 4th quarter valued at about $345,000. Greenhouse Funds LLLP raised its stake in Confluent by 102.2% during the 4th quarter. Greenhouse Funds LLLP now owns 1,820,446 shares of the company's stock valued at $50,900,000 after buying an additional 919,997 shares during the last quarter. Finally, Stifel Financial Corp lifted its holdings in Confluent by 2.7% in the fourth quarter. Stifel Financial Corp now owns 42,475 shares of the company's stock valued at $1,188,000 after acquiring an additional 1,136 shares during the period. 78.09% of the stock is currently owned by hedge funds and other institutional investors.
Confluent Stock Up 3.0 %
Shares of NASDAQ:CFLT traded up $0.58 during midday trading on Friday, reaching $20.02. The company's stock had a trading volume of 8,049,575 shares, compared to its average volume of 4,668,353. Confluent, Inc. has a 12-month low of $17.79 and a 12-month high of $37.90. The company has a quick ratio of 4.24, a current ratio of 3.99 and a debt-to-equity ratio of 1.14. The firm has a 50 day moving average of $24.66 and a 200-day moving average of $27.40. The firm has a market capitalization of $6.69 billion, a P/E ratio of -18.56 and a beta of 1.03.
Confluent (NASDAQ:CFLT - Get Free Report) last announced its earnings results on Wednesday, April 30th. The company reported $0.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.07 by $0.01. Confluent had a negative return on equity of 34.70% and a negative net margin of 35.81%. The business had revenue of $271.12 million for the quarter, compared to analysts' expectations of $264.45 million. During the same period last year, the firm posted $0.05 earnings per share. The business's revenue for the quarter was up 24.8% on a year-over-year basis. On average, research analysts anticipate that Confluent, Inc. will post -0.83 earnings per share for the current year.
Analysts Set New Price Targets
A number of equities analysts have recently weighed in on CFLT shares. William Blair reaffirmed an "outperform" rating on shares of Confluent in a research note on Monday, March 17th. Robert W. Baird lowered their price target on shares of Confluent from $37.00 to $24.00 and set a "neutral" rating for the company in a research report on Thursday. Canaccord Genuity Group lowered their price target on Confluent from $38.00 to $32.00 and set a "buy" rating for the company in a research report on Thursday. Oppenheimer reduced their price target on Confluent from $35.00 to $32.00 and set an "outperform" rating for the company in a report on Thursday. Finally, JMP Securities cut their price objective on Confluent from $40.00 to $36.00 and set a "market outperform" rating on the stock in a research report on Thursday. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, twenty-two have issued a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $30.28.
Read Our Latest Research Report on CFLT
Insider Activity
In other Confluent news, insider Erica Schultz sold 150,000 shares of Confluent stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $35.82, for a total transaction of $5,373,000.00. Following the completion of the sale, the insider now directly owns 678,016 shares of the company's stock, valued at $24,286,533.12. The trade was a 18.12 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Edward Jay Kreps sold 232,500 shares of the firm's stock in a transaction dated Thursday, February 20th. The shares were sold at an average price of $32.33, for a total value of $7,516,725.00. Following the sale, the chief executive officer now directly owns 452,488 shares in the company, valued at approximately $14,628,937.04. The trade was a 33.94 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 1,200,746 shares of company stock worth $38,505,150 over the last quarter. Insiders own 13.82% of the company's stock.
Confluent Profile
(
Free Report)
Confluent, Inc operates a data streaming platform in the United States and internationally. The company provides platforms that allow customers to connect their applications, systems, and data layers, such as Confluent Cloud, a managed cloud-native software-as-a-service; and Confluent Platform, an enterprise-grade self-managed software.
Featured Stories

Before you consider Confluent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Confluent wasn't on the list.
While Confluent currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.